Comparison of Subcostal & Transhepatic Views to Assess NCT03587090

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Completed

Comparison of subcostal and transhepatic views to measure inferior vena cava diameter by echocardiography in intensive care unit patients

Recruitment information / eligibility
Status	Completed
Enrollment	131
Est. completion date	October 4, 2019
Est. primary completion date	October 4, 2019
Accepts healthy volunteers	No
Gender	All
Age group	18 Years and older
Eligibility	Inclusion Criteria: - patient hospitalised in ICU Exclusion Criteria: - gardianship - contraindication to transthoracic echocardiography

Diagnostic Test:
• echocardiography
echocardiography by subcostal and transhepatic views

Locations
Country	Name	City	State
France	Service de réanimation médicale CHU de Caen	Caen

Sponsors *(1)*
Lead Sponsor	Collaborator
University Hospital, Caen

France,

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	inferior vena cava diameter	measurement of inferior vena cava diameter by 2D et TM mode	up to 1 day after inclusion